Respiratory critical care
Respiratory infections
Hot topics
How science conquered COVID-19: from big platform trials to patients
Translational
COVID
Aims : To describe ground-breaking news about phenotyping and managing acute hospitalised COVID patients; to describe several key studies, results and advances including the recent RECOVERY-RS study of respiratory support, phenotyping to assist risk stratification and the results of the international RECOVERY and REMAP-CAP trials.
Target audience :
Adult pulmonologist/Clinician, Clinical researcher, Medical Student, Respiratory critical care physician, Physician in Pulmonary Training, Respiratory therapist
11:15
Introduction
1
2984
11:20
Phenotypes in acute COVID: lessons from the multicentre studies
C. Summers(Cambridge (Cambridgeshire), United Kingdom)
COI
-
Description
2
2985
11:35
Needing oxygen in COVID? Acute respiratory support (RECOVERY-RS), continuous positive airway pressure, high-flow nasal oxygen and other approaches controversies
G. Perkins(Birmingham (West Midlands), United Kingdom)
COI
-
Description
3
2986
11:50
Research prioritisation in long COVID: using patients and experts to develop an international consensus
L. Daines(Edinburgh (Edinburgh), United Kingdom)
COI
-
Description
4
2987
12:05
What have we learned from big platform trials of COVID? RECOVERY, REMAP-CAP and others
L. Derde(Utrecht, Netherlands)
COI
-
Description
5
2988
12:20
Discussion and Q&A
6
2989
. . .
